Lejárt a biztonsági időkorlát.
Ha az oldal űrlapot is tartalmaz, annak mentése csak érvényes bejelentkezéssel lehetséges.
A bejelentkezés érvényességének meghosszabbításához kérjük lépjen be!
Felhasználó név:
Jelszó:
 


Publikációs adatbázise-GFR kalkulátorKidney and Blood Pressure ResearchHypertonia és Nephrologia
március
  • H
  • K
  • S
  • C
  • P
  • S
  • V
  •  
  •  
  •  
  •  
  • 1
  • 2
  • 3
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31

    Az MANET hírarchívuma


    Hírkategória: Összes hírkategória
    • EDITH Nephrologist survey
      [2019.05.13.] - MANET - Hírkategória: Általános
      Dear Colleague,

      This week is the last chance to complete the online EDITH Nephrologist survey!

      The ERA-EDTA Registry is participating in EDITH. In this large EU project we focus on the causes of differences in the provision of dialysis and kidney transplantation across Europe. For more information about EDITH, please visit https://edith-project.eu/

      Through the EDITH Nephrologist survey we would like to study the barriers that nephrologists and kidney transplant surgeons experience when providing RRT or comprehensive conservative management to patients with ESKD.

      Hereby we invite you to complete the EDITH Nephrologist survey.

      Who can participate?
      All practising nephrologists and nephrology trainees in Europe who treat adult patients by dialysis, kidney transplantation or comprehensive conservative management and all kidney transplant surgeons.

      Practical information
      - You can find the survey at the ERA-EDTA Registry website: www.era-edta-reg.org
      - The survey is available online, in English and takes 15-20 minutes to fill out.
      - The closing date is May 19, 2019.

      Ethics approval
      This survey has received a waiver from the Medical Ethics Committee of the Amsterdam University Medical Centers (UMC) – location AMC, Amsterdam, the Netherlands and we were informed that no additional review was necessary in your country.

      Let your voice be heard and show the European Union what nephrology needs in order to offer the most suitable treatment modality to each patient with ESKD!

      Thank you in advance for your help.

    Vissza